Mode
Text Size
Log in / Sign up

Hepatic MPNST without NF1: normal tumor markers, no recurrence 2 years after resectionCase Report Shows Surgery for Rare Liver Tumor Success

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider hepatic MPNST in the differential of hypovascular liver masses with normal tumor markers, even without NF1.

This is a case report and literature review of a 56-year-old woman with hepatic malignant peripheral nerve sheath tumor (MPNST) in the absence of neurofibromatosis type 1. The tumor presented as a hypovascular hepatic lesion on contrast-enhanced ultrasound and computed tomography, with serum tumor markers within normal ranges. The patient underwent radical tumor resection and showed no signs of recurrence or metastasis at approximately 2 years of follow-up.

The review synthesizes available literature on imaging features of hepatic MPNST, noting that contrast-enhanced ultrasound and contrast-enhanced computed tomography manifestations are non-specific and require differentiation from other liver malignancies such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and hepatic angiosarcoma. The authors highlight that hepatic MPNST presents with non-specific clinical features and normal tumor markers, making preoperative diagnosis challenging.

Key limitations include the small sample size (single case report) and limited available data on this rare entity. The evidence is insufficient to guide management beyond surgical resection. Practice relevance is confined to raising awareness of this rare tumor in the differential diagnosis of liver masses, especially when tumor markers are normal and imaging shows a hypovascular lesion.

How this fits prior evidence

This case report extends prior coverage of NF1-associated tumors by describing hepatic MPNST in a patient without NF1, contrasting with earlier cases that involved NF1 patients. Unlike the May 2026 case report of spontaneous hemorrhage in NF1, this case showed no acute bleeding. It adds to the limited literature on MPNST outside NF1, complementing the March 2026 report on malignant triton tumor in NF1 by highlighting a different histologic variant and anatomic site.

Doctors reported on a 56-year-old woman who had a rare type of cancer in her liver called a malignant peripheral nerve sheath tumor (MPNST). This specific condition is uncommon and can be difficult to identify because it often looks like other types of liver cancer. The patient underwent a radical surgery to remove the tumor.

After the procedure, the patient was monitored for about two years. During this time, her blood tests showed normal tumor markers, and imaging scans did not show any signs of the cancer returning or spreading. These results suggest that surgical removal can be an effective way to manage this specific type of liver tumor.

Because this report only covers one person, it is very early information for such a rare condition. Doctors use these cases to help identify similar tumors in other patients. Because symptoms are often unclear, it remains important for doctors to carefully distinguish this cancer from more common liver diseases.

What this means for you:
A single case shows that surgery can successfully treat a rare liver tumor with no recurrence after two years.

Common questions

What is an MPNST and how was it treated?

An MPNST is a rare type of tumor. In this specific case, the patient had one in her liver. The medical team performed a radical tumor resection to remove it. This surgery successfully removed the tumor, and no signs of recurrence or metastasis were found during the two-year follow-up period.

How is this condition identified?

This condition can be hard to identify because its clinical features are not specific. It can look like other liver cancers, such as hepatocellular carcinoma or hepatic angiosarcoma. Doctors use imaging tools like CEUS and CECT to help see the tumor's appearance on scans.

Were there any side effects from the treatment?

The report did not provide specific details regarding side effects or complications following the surgery. Because this was a single case study, more information would be needed to determine the overall tolerability of the procedure for other patients.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundMalignant peripheral nerve sheath tumor (MPNST) is a malignant neoplasm originating from Schwann cells or other nerve sheath components. It most commonly arises in the extremities and trunk. Primary hepatic MPNST is extremely rare, and most cases are associated with neurofibromatosis type 1 (NF-1).Case presentationThis study reports a rare case of hepatic MPNST without NF-1 in a 56-year-old female. The patient presented with upper abdominal pain and distention. Serum tumor markers were all within normal ranges. Radiological examination identified a hypovascular hepatic lesion, which was pathologically confirmed as MPNST. Radical tumor resection was performed. The patient has been followed up for approximately 2 years, with no signs of recurrence or metastasis.ConclusionThe clinical manifestation of hepatic MPNST is nonspecific with normal tumor markers. Radiologically, it mainly manifests as a hypovascular tumor, which requires differentiation from hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and hepatic angiosarcoma. With a literature review, our article provides a comprehensive summary of its CEUS and CECT manifestations, thereby supplementing the limited available data on this rare entity.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.